Rivaroxaban 10mg tablets
Indication
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and extended prevention of recurrent DVT and PE in adults
NICE TA261 - Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Amber level 0
Brand:
Xarelto®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Cardiovascular system
Background
Rivaroxaban 10mg is recommended for treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and extended prevention of recurrent DVT and PE in adults after initial treatment, as described in NICE TA261.
• Suitable for prescribing in primary care following recommendation or initiation by a specialist.
• Little or no specific monitoring required.
• Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care.
• Brief prescribing document or information sheet may be required.
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: